Parth Mehrotra Sells 15,647 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 15,647 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $22.64, for a total value of $354,248.08. Following the sale, the chief executive officer owned 434,357 shares of the company’s stock, valued at approximately $9,833,842.48. The trade was a 3.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Parth Mehrotra also recently made the following trade(s):

• On Monday, May 11th, Parth Mehrotra sold 105,439 shares of Privia Health Group stock. The shares were sold at an average price of $22.55, for a total value of $2,377,649.45.
• On Monday, March 16th, Parth Mehrotra sold 26,509 shares of Privia Health Group stock. The stock was sold at an average price of $22.11, for a total value of $586,113.99.
• On Friday, March 13th, Parth Mehrotra sold 27,229 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total value of $585,968.08.
• On Thursday, March 12th, Parth Mehrotra sold 26,763 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total value of $586,109.70.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The stock was sold at an average price of $22.71, for a total value of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total value of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Stock Up 2.7%

Shares of PRVA stock opened at $23.24 on Friday. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51. The company has a market cap of $2.93 billion, a P/E ratio of 145.26, a P/E/G ratio of 1.66 and a beta of 0.96. The business has a fifty day simple moving average of $22.64 and a 200 day simple moving average of $23.23.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.11. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The business had revenue of $603.85 million during the quarter, compared to the consensus estimate of $560.99 million. During the same period in the prior year, the company earned $0.22 EPS. Privia Health Group’s revenue for the quarter was up 25.8% on a year-over-year basis. As a group, equities research analysts anticipate that Privia Health Group, Inc. will post 0.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on PRVA shares. Jefferies Financial Group reiterated a “buy” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Thursday, February 26th. Weiss Ratings downgraded Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Barclays increased their target price on Privia Health Group from $23.00 to $25.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 25th. Truist Financial increased their target price on Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Finally, Canaccord Genuity Group dropped their target price on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $31.23.

Institutional Investors Weigh In On Privia Health Group

Several institutional investors and hedge funds have recently made changes to their positions in PRVA. Van Berkom & Associates Inc. increased its stake in shares of Privia Health Group by 30.1% in the third quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock valued at $93,987,000 after buying an additional 873,344 shares during the period. Vanguard Group Inc. increased its stake in shares of Privia Health Group by 5.3% in the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock valued at $301,263,000 after buying an additional 607,447 shares during the period. ArrowMark Colorado Holdings LLC increased its stake in shares of Privia Health Group by 139.4% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company’s stock valued at $19,946,000 after buying an additional 489,866 shares during the period. Algert Global LLC increased its stake in shares of Privia Health Group by 277.4% in the third quarter. Algert Global LLC now owns 484,304 shares of the company’s stock valued at $12,059,000 after buying an additional 355,966 shares during the period. Finally, Freestone Grove Partners LP increased its stake in shares of Privia Health Group by 40.6% in the fourth quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock valued at $28,768,000 after buying an additional 350,194 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.